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Abstract:           
Background: The association of genital microorganism with infertility has been documented but no 
consensus exists. Understanding their prevalence amongst infertile clients may assist in facilitating 
better screening protocols. The objective of this study is to determine the prevalence of 
microorganisms routinely screened among women undergoing infertility evaluation at the University of 
Benin Teaching Hospital.                       
Methods: A three year (January 2015 to December 2017) retrospective survey of all patients 
evaluated for infertility at the assisted reproduction unit of the hospital was undertaken. Chlamydia 
trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, cytomegalovirus (CMV), hepatitis B 
(HBV), hepatitis C (HCV) virus and the human immunodeficiency virus (HIV) were microorganisms 
serologically assayed at the unit. We analyzed data containing patients’ demography and results of 
serological assay of these microorganisms.                        
Results: There were 576 patients (288 couples) who completed their microbiological evaluation 
during the study period. The mean age (years) of female partners was 38.2±5.7, while the mean age 
of the male partners was 42.7±6.1. The frequency of CMV positive assay for infertile couples was 129 
(22.4%); C. trachomatis 125 (21.7%); M. hominis 92 (15.9%) and U. urealyticum 76 (13.2%). 
Overall, more women (50.7%) were seropositive compared to men (26%). HIV was positive in 10 
patients (1.73%) with 60% being women. HBV was seropositive in 8 (1.4%) (women 62.5% and men 
37.5%) while HCV was positive in only 2 (0.3%) patient. Majority (over 80%) of couples were sero-
discordant with 20% (2) concordance rate for HIV and 12.5% (1) for hepatitis B.                 
Conclusion: Despite a relatively high seroprevalence rate of the studied microorganisms, the 
documented uncertainty on their association with infertility or its treatment limits justification for 
incorporation of routine screening of microbiological organisms into standard protocols for evaluation 
of infertile couples. A robust study on the impact of genital microorganism on specific infertility 
variables with comparison to fertile controls is recommended. 
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Abstrait: 
Contexte: L'association d'un microorganisme génital à l'infertilité a été documentée mais il n'y a pas 
de consensus. Comprendre leur prévalence chez les clients infertiles peut aider à faciliter de meilleurs 
protocoles de dépistage. L’objectif de cette étude est de déterminer la prévalence des micro-
organismes régulièrement dépistés chez les femmes subissant une évaluation de la stérilité à l’hôpital 
universitaire de Bénin.                           
Méthodes: Une enquête rétrospective de trois ans (de janvier 2015 à décembre 2017) sur tous les 
patients évalués pour l'infertilité dans l'unité de procréation assistée de l'hôpital a été entreprise. 
Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, cytomégalovirus (CMV), 
l'hépatite B (VHB), le virus de l'hépatite C (VHC) et le virus de l'immunodéficience humaine (VIH) 
étaient des microorganismes testés sérologiquement à l'unité. Nous avons analysé les données 
contenant la démographie des patients et les résultats du dosage sérologique de ces micro-
organismes.                           
Résultats: 576 patients (288 couples) ont terminé leur évaluation microbiologique au cours de la 
période d'étude. L'âge moyen (en années) des partenaires féminins était de 38,2 ± 5,7 ans, tandis 
que l'âge moyen des partenaires masculins était de 42,7 ± 6,1. La fréquence du test CMV-positif pour 
les couples infertiles était de 129 (22,4%); C. trachomatis 125 (21,7%); M. hominis 92 (15,9%) et U. 
urealyticum 76 (13,2%). Dans l'ensemble, plus de femmes (50,7%) étaient séropositives que 
d'hommes (26%). Le VIH était positif chez 10 patients (1,73%), dont 60% de femmes. Le VHB était 
séropositif chez 8 (1,4%) (les femmes 62,5% et les hommes 37,5%), tandis que le VHC était positif 
chez seulement 2 patients (0,3%). La majorité (plus de 80%) des couples étaient sérodiscordants 
avec un taux de concordance de 20% pour le VIH et de 12,5% (1) pour l'hépatite B.                  
Conclusion: Malgré un taux de séroprévalence relativement élevé des microorganismes étudiés, 
l'incertitude documentée de leur l'association à l'infertilité ou à son traitement limite la justification de 
l'incorporation du dépistage systématique des organismes microbiologiques dans les protocoles 
standard d'évaluation des couples infertiles. Une étude robuste sur l'impact des microorganismes 
génitaux sur des variables spécifiques d'infertilité comparées aux témoins fertiles est 
Mots-clés: microorganisme, virus, infertilité, procréation assistée, test sérologique, dépistage 
Introduction: 
 Genital microbial infections can 
influence the fertility potential of a couple. 
Common pathogenic species implicated in 
both genital infections and infertility are 
Chlamydia trachomatis, Genital urea- 
plasmas (Ureaplasma urealyticum and 
Ureaplasma parvum) and mycoplasmas 
(Mycoplasma genitalium and Mycoplasma 
hominis) as well as viruses such as 
cytomegalovirus, human immuno- 
deficiency virus and hepatitis viruses. The 
causal role of C. trachomatis in infertility 
is reasonably defined, as it may cause 
pelvic inflammatory disease with resultant 
tubal factor infertility and ectopic 
pregnancy (1, 2).   
 Chronic viral infections have been 
found to be a risk during infertility 
treatment (3, 4). In a previous work, 
hepatitis B was reported as the most 
prevalent of the viral infection detected 
amongst infertile couple (5). Another 
research showed that hepatitis C virus 
(HCV) seropositive women had decreased 
response during ovarian stimulation at 
assisted reproduction treatment cycles 
(4). Mycoplasma and Ureaplasma species 
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have been associated with increased risk 
of genitourinary tract infections and 
recurrent pregnancy losses (6, 7). Their 
role in the aetiology of infertility is still 
speculative but they may impair 
fertilization or implantation. Ureaplasma 
urealyticum and M. hominis have been 
demonstrated to affect semen quality of 
infertile men, with recovery of the 
organisms in 7–14% of semen samples of 
infertile men (8, 9).    
 Human Cytomegalovirus (CMV) 
also known as human herpesvirus-5 
(HHV-5) is the most studied of all CMVs. 
Human CMV infection is typically non 
pathogenic but can be life-threatening for 
the immuno-compromised patients such 
as organ transplants recipients, newborn, 
infants or HIV-infected persons. Some 
studies have shown that CMV may play a 
significant role in male infertility, and its 
early detection will permit successful 
antiviral therapy, to increase the fertility 
potential of the individual (10, 11). 
 It is with this foregoing that, some 
guidelines have recommended that 
women should be screened for C. 
trachomatis or given appropriate antibiotic 
prophylaxis, before any uterine instru- 
mentation takes place with regard to 
infertility patients receiving invitro 
fertilization (IVF) treatment (12, 13). For 
this reason many centres with assisted 
reproduction units have evolved guidelines 
for evaluation of the infertile couple to 
include detailed history, physical 
examination and laboratory analyses. 
However the genital microbial infection 
screening protocol still varies for different 
institutions. Hence the prevalence of these 
infections in the couples undergoing 
infertility evaluation is still uncertain.
 The University of Benin Teaching 
Hospital (UBTH) is a public tertiary 
healthcare centre offering assisted 
reproduction services in a population 
characterized by deepening economic and 
resource constraints, and poor health 
seeking behavior. The benefit of screening 
for the aforementioned micro-organisms 
while evaluating infertile couple in the 
overall interest of their reproductive 
health is underscored in the goal of 
improving success of infertility treatment 
as well as opportunistic detection of these 
infections in apparently healthy 
individuals.     
 In sub-Saharan Africa, reports of 
prevalence and significance of these key 
micro-organisms that may influence 
overall reproductive health of the infertile 
couple are limited in the literature. This 
study aims to determine the prevalence of 
C. trachomatis, U. urealyticum, M. 
hominis, cytomegalovirus (CMV), hepatitis 
B (HBV) and C (HCV) virus and the human 
immunodeficiency virus (HIV) among 
women undergoing infertility evaluation.  
Methods:  
Study design and setting:               
 A retrospective survey of all 
patients evaluated for infertility at Human 
Reproduction and Research Programme 
(HRRP) unit of University of Benin 
Teaching Hospital (UBTH) was undertaken 
between January 2015 and December 
2017. The HRRP is a dedicated infertility 
treatment unit of the hospital with 
services for Invitro Fertilization (IVF) and 
other assisted reproduction techniques 
(ART). Evaluation of infertility at the unit 
is in line with global standard guideline on 
the investigation of infertile couples.(12) 
In addition routine screening for micro- 
organism is done specifically for C. 
trachomatis, U. urealyticum, M. hominis, 
cytomegalovirus (CMV), hepatitis B (HBV) 
and C (HCV), and human immuno- 
deficiency virus (HIV) infections.  
Serological methods:    
    Rapid test strip was the principal 
method for microorganism detection in 
this study. Colloidal Gold Immuno-
filtration (GIFA) Assay was used to 
qualitatively detect U. urealyticum, M. 
genitalium and C. trachomatis antibody in 
human serum. Qualitatitive detection of 
viral antibodies in serum or plasma was 
with Rapid test chromatographic immuno- 
assay. Those with positive serological 
results were counseled and managed as 
appropriate. Approval for the study was 
obtained from the institutions Ethics and 
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Research Committee.   
 Case files of patients who 
presented for initial infertility evaluation 
during the selected study period were 
retrieved. All clients with completed 
laboratory work-up results were included 
for analysis. The data extracted were 
analyzed using InStat Graph Pad and 
presented in the form of frequency tables 
and descriptive statistics. Chi square test 
was used to test for statistical difference 
where appropriate and p value of less 
than 0.05 was considered significant. 
Results: 
 Overall, 576 patients (288 couples) 
completed their microbiological evaluation 
during the study period and these were 
extracted for analysis. The age (years) of 
female partners ranged from 23 to 56 and 
the mean was 38.2±5.7, while the mean 
age of the male partners was 42.7±6.1 
and a range of 31 to 63. On the whole 
seropositive detection rate was 76.7% 
(442/576) with 292 (50.7%) being 
seropositive female and 150 (26.0%) for 
male. Overall sero-concordance rate was 
10.8% (62/576). It is pertinent to note 
that some patients were seropositive for 
more than one microbial organism.  
 Cytomegalovirus was the 
commonest organism detected amongst 
infertile couples (Table 1) with frequency 
of seropositivity for immunoglobulin G of 
129 (22.4%); female 88 (68.2%) and 
male 41 (31.8%). One hundred and 
twenty-five (21.7%) were seropositive for 
C. trachomatis; 81 (64.8%) female and 
44 (35.2%) male. Ninety-two (15.9%) 
were seropositive for M. hominis; female 
64.1% and male 35.9%, and 76 (13.2%) 
were seropositive for U. urealyticum 
(female 68.4% and male 31.6%).  
 Also shown in Table 1 is the 
frequency of couples with concordant 
positive test; 5.3%, 5.4%, 19.4% and 
20.0% for ureaplasma, mycoplasma, 
cytomegalovirus, and chlamydia resp- 
ectively. Other organisms screened for 
routinely are shown; HIV was positive in 
10 patients (1.73%) with 6 (60%) female 
and 4 (40%) male. Hepatitis B was 
seropositive in 8 (1.4%) with females 
62.5% (5) and male 37.5% (3); hepatitis 
C was positive in only 2 (0.3%) patients. 
Majority of couples were sero-discordant 
with 20% (2) concordance rate for HIV 
and 12.5% (1) for hepatitis B. 
 Comparison of microorganism 
seroprevalence rate between female and 
male patients (Table 2) showed that for 
Chlamydia, Ureaplasma, Mycoplasma and 
Cytomegalovirus, significantly more 
females were infected compared to males 
(p<0.05), however there was no 
statistical difference between female and 
male seroprevalence for HIV, HBV and 
HCV (p>0.05). 
 
Table 1: Seroprevalence of microorganisms in subjects evaluated for infertility at UBTH Benin between                  
January 2015 and December 2017 







No of couples 
Ureaplasma urealyticum 
 
76 (13.2) 64 (69.6) 28 (30.4) 4 (5.3) 
Mycoplasma hominis 
 
92 (15.9) 56 (73.7) 20 (26.3) 5 (5.4) 
Chlamydia trachomatis 
 
125 (21.7) 88 (66.7) 44 (33.3) 25 (20.0) 
Cytomegalovirus 
 




10 (1.7) 6 (2.1) 4 (1.4) 2 (20) 
Hepatitis B Virus 
 
8 (1.4) 5 (1.7) 3 (1.0) 1 (12.5) 
Hepatitis C Virus 2 (0.3) 1 (0.3) 1 (0.3) 0 
Total 442 (76.7) *292 (50.7) 150 (26.0) 62 (10.8) 
n = number of subjects screened, * = some subjects were seropositive for more than one organism 
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52 (18.1) 24 (8.3) 0.001* 1.45 (1.21-1.73) 
Mycoplasma hominis 
 
59 (20.5) 33(11.5) 0.004* 1.36 (1.13-1.62) 
Chlamydia trachomatis 
 
81 (28.1) 44 (15.3) 0.001* 1.41 (1.19-1.66) 
Cytomegalovirus 
 




6 (2.1) 4 (1.4) 0.749 1.2 (0.72-2.01) 
Hepatitis B Virus 
 
5 (1.7) 3 (1.0) 0.721 1.25 (0.72-2.16) 
Hepatitis C Virus 1 (0.3) 1 (0.3) 1 1 (0.25-4.12) 
n = number of subjects screened, * = significant difference p< 0.05 
Discussion:  
 The association of genital microbial 
infection and infertility is still not explicit. 
Hence there is no clear consensus 
guideline with regard to screening for 
these microorganisms during infertility 
evaluation. In this study, the high 
seroprevalence rate of microorganisms of 
over 75% apparently supports the call for 
routine screening for genital microbial 
infection at the infertility clinic. However, 
this finding cannot be generalized or 
equated to individual patients as some 
were seropositive for multiple micro- 
organisms. With regards to specific genital 
microorganism in this study, the most 
frequent organisms (cytomegalovirus and 
chlamydia) had seroprevalence rate of 
about 22%. This finding is similar to those 
of Rodriguez and co workers (14) who 
reported a seroprevalence rate of 23.5% 
for the most common microorganism 
detected (ureaplasma) although the 
organism was different from those from 
this study.     
 Our findings are also comparable 
to reported seroprevalence rate of 19.2% 
and 15.2% respectively for genital 
mycoplasma and ureaplasma among 
infertile male patients (15). Similar 
studies in southern Nigeria have reported 
prevalent rates among patients with 
infertility (16, 17) but while the rate in our 
study is higher than some previously 
reported in this environment, it is lower 
than others (8, 18, 19). Although, the 
exact role of genital microbial infection in 
infertility is not clearly defined, previous 
researchers have documented microbial 
infections of the genital tract or semen as 
causes of male infertility (16, 20). Another 
study that investigated the association 
between genital ureaplasmas and myco- 
plasmas and risk of infertility showed a 
significantly higher positive rate of 
U. urealyticum and M. hominis in the 
infertile compared to control group but 
there was no significant causal association 
with male infertility (21).   
 The seroprevalence was similar to 
that observed in this study although we 
did not compare with fertile controls. 
Evidently C. trachomatis infection in 
women has been implicated in tubal factor 
infertility and tubal ectopic pregnancy but 
its sequelae in men, is still unclear (2). 
Similarly, the role of cytomegalovirus in 
infertility is also doubtful. Some 
researchers reported that while sero-
prevalence rate and shedding of 
cytomegalovirus in the genital tracts of 
infertile patients are relatively high, this 
seem to have no significant role on 
infertility (11). Also there was no 
difference in sperm count and motility 
between those with and without 
cytomegalovirus infections (11, 24). 
Notwithstanding, the high seroprevalence 
rate reported is consistent with the finding 
of cytomegalovirus being the commonest 
detected microorganism in our study.
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 The seroprevalence of other 
viruses (HIV, HBV and HCV) studied were 
low and comparable to previous research 
on viral infections amongst infertile 
couples (25). HCV seroprevalence in our 
study is lower compared to a previous 
study in our centre which investigated 
HCV prevalence amongst antenatal clinic 
attendees (26). A higher HCV rate of 
3.2% amongst infertile couples has been 
reported in Brazil (27). The implications of 
these transmissible viral infections (HIV, 
HBV and HCV) on infertility management 
at assisted reproduction are quite est- 
ablished and unambiguous. These include 
issues of cross-contamination in the 
laboratory and vertical transmission with 
possible deleterious consequences. Also, 
HCV infection has been reported to 
negatively affect ovarian response during 
stimulation (3, 13, 27).  
 From the foregoing screening for 
genital microbial infections at infertility 
evaluation is important. Our finding of a 
relatively high seroprevalence and the 
negative influence of these micro 
organisms on an individuals’ fertility 
potential supports the consideration for 
incorporating genital microorganism 
screening into routine infertility evaluation 
protocol. This may facilitate better 
screening protocols and improve infertility 
treatment outcome. In addition it will 
afford the opportunity for patients to be 
referred to appropriate caregivers for 
other treatment and follow-up. Although 
guidelines for routine screening for 
transmissible viruses such as HIV, HBV 
and HCV are well established, there is still 
no consensus recommendation for routine 
screening for other genital micro 
organisms during infertility evaluation. 
This is largely due to the uncertainty 
regarding the role and association of these 
microorganisms and infertility.  
 In conclusion the observed sero- 
prevalence of microbial organisms 
amongst infertile couples in this study is 
in line with global average. However while 
the utility of routine screening of a 
population seeking infertility treatment is 
not in doubt, there is no consensus on 
relevance and effect of these genital 
microorganisms on infertility or its 
treatment. Furthermore since this study 
focused on prevalence and not the effect 
of the organisms, justification and 
generalization on screening protocols for 
the aforementioned organisms during 
infertility evaluation is limited. 
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